Condition
Coronavirus-19
Total Trials
6
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
P 1 (2)
P 2 (3)
Trial Status
Completed3
Withdrawn2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04335084Phase 2Completed
A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection
NCT04359836Recruiting
A Study to Explore the Role of Gut Flora in COVID-19 Infection
NCT04482686Phase 1Completed
Trial of Combination Therapy to Treat COVID-19 Infection
NCT04334512Phase 2Completed
A Study of Quintuple Therapy to Treat COVID-19 Infection
NCT04459702Phase 2Withdrawn
A Study of Combination Therapies to Treat COVID-19 Infection
NCT04395716Phase 1Withdrawn
A Study of ResCure™ to Treat COVID-19 Infection
Showing all 6 trials